Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup — Stella

Recruiting

Back to Oligometastatic Lung Tumor trials

Trial locations(2 sites)

France

Montpellier Cancer Institut, Montpellier, ICM

Lorraine Cancer Institute, Vandœuvre-lès-Nancy

Key details

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Enrollment target

~190 participants

Started

January 2026

Primary completion

November 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov